CellChorus
PrivateLast Round
Grant
Aug 25, 2025
Total Funding Raised
$3.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CellChorus operates in Healthcare & Life Sciences and is based in Houston, Texas. Its latest recorded funding round was a Grant round in August 2025.
CellChorus is a biotechnology company that has developed a visual artificial intelligence platform for high-throughput, dynamic single-cell analysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Medical Imaging, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CellChorus Comparables
Compare CellChorus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Celldom | 86% | |
| Enrich Biosystems | 80% | |
| ARRALYZE | 76% |
For institutional investors. Book with your work email.
CellChorus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 25, 2025 | ||||
| Grant | May 2, 2024 | ||||
| Grant | Jun 28, 2023 | ||||
| Grant | Jun 21, 2023 | ||||
| Accelerator | Aug 31, 2021 |
For institutional investors. Book with your work email.
CellChorus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| Y Combinator | Accelerator |
| BioTools Innovator | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 386% MoM, reaching 2.1K.
- May 17, 2026
Monthly visitors grew 259% MoM, from 375 to 1.3K.
For institutional investors. Book with your work email.
CellChorus Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CellChorus's valuation, stock price, and market status.
Is CellChorus a public or private company?
CellChorus is a private company.
What is the current stock price of CellChorus?
CellChorus is a private company, so its shares have no public market price. Caplight tracks CellChorus's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CellChorus worth (valuation)?
Valuation information for CellChorus is not publicly available.
Can I buy CellChorus stock?
CellChorus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CellChorus's last funding round?
CellChorus's most recent funding round was Grant on August 25, 2025.
Who are the main investors in CellChorus?
Key investors in CellChorus include Y Combinator, National Science Foundation.
Will CellChorus IPO soon?
No public IPO plans have been announced for CellChorus.
How can I track CellChorus secondary market activity?
Caplight tracks bids, offers, and trades in CellChorus's shares on secondary markets.